First Shipments to Kuwait
"Record Number for Korean Toxin Brands"

Daewoong Pharmaceutical's botulinum toxin product ‘NABOTA’ has achieved product launches in seven Middle Eastern countries.


Daewoong Pharmaceutical announced on the 30th that, with NABOTA beginning its first shipments to Kuwait this month, it has now launched its product in a total of seven Middle Eastern countries, including Saudi Arabia, the United Arab Emirates, Türkiye, Qatar, Egypt, and Bahrain.


Map of Nabota's Expansion Status in the Middle East. Daewoong Pharmaceutical

Map of Nabota's Expansion Status in the Middle East. Daewoong Pharmaceutical

View original image

The company explained, “This is the highest number among Korean botulinum toxin companies,” adding, “It signifies that NABOTA has established itself as the Korean toxin product with the most advanced entry foundation in the Gulf Cooperation Council (GCC) region and the wider Middle Eastern premium aesthetics market.”


Daewoong Pharmaceutical plans to leverage this entry to position Kuwait as a strategic base for expanding its business in the Middle East and will continue to strengthen the brand's competitiveness within the GCC market.


The company, in collaboration with its local partner, will officially launch NABOTA in October and hold a launch symposium. Approximately 200 local healthcare professionals, including key opinion leaders (KOLs) from both the public and private sectors, will be invited. A Korean dermatologist will also be invited as a presenter to share clinical experiences with NABOTA.


Daewoong Pharmaceutical intends to expand interactions with healthcare professionals through nationwide direct sales and marketing activities, active participation in major conferences, and offering cadaver courses.



Yoon Joonsoo, Head of the NABOTA Business Division at Daewoong Pharmaceutical, stated, “Our entry into Kuwait is an important milestone, marking NABOTA's breakthrough of KRW 1 trillion in cumulative sales and signaling the start of a full-scale strategy for the GCC market as we step up as a global premium brand. Based on differentiated product competitiveness and local partnerships, we will earn the trust of both healthcare professionals and consumers, so that NABOTA can become Korea's representative toxin brand and establish itself as a premium leader in the Kuwaiti market.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing